Campbell, Ca., August 1, 2008 - Hunter Labs and Boston Heart Lab (BHL) Partnership

Hunter Laboratories, Inc. announced today that it has entered into a partnership Agreement with the Boston Heart Lab to provide the most complete, individualized Coronary Heart disease risk analysis and treatment options for N CA physicians. Through a combination of proprietary lipid tests, advanced therapy guidelines, and patient support services Hunter Labs will assist physicians in delivering the best possible cardiovascular health to their patients based on each patient’s individual profile. The proprietary lipid tests include sterol analysis and two dimensional gel HDL fingerprinting, which facilitate the management of drug effectiveness with higher specificity and speed than traditional tests.

Hunter Labs Medical Director, Gerry Weiss, MD, commented that he is excited to work with two of the most respected leaders in cardiovascular research: BHL’s Ernst Schaeffer MD and Bella Asztalos, Phd.